R

Avidity Biosciences
D

RNA

13.250
USD
-0.21
(-1.59%)
مغلق
حجم التداول
4,179
الربح لكل سهم
-6
العائد الربحي
-
P/E
-2
حجم السوق
226,649,770
المقالات
المزيد

العنوان: Atrium Therapeutics Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.